A proteomic signature for dementia with Lewy bodies

INTRODUCTION: We sought to determine if a proteomic profile approach developed to detect Alzheimer's disease would distinguish patients with Lewy body disease from normal controls, and if it would distinguish dementia with Lewy bodies (DLB) from Parkinson's disease (PD). METHODS: Stored pl...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Bryant, Sid E., Ferman, Tanis J., Zhang, Fan, Hall, James, Pedraza, Otto, Wszolek, Zbigniew K., Como, Tori, Julovich, David, Mattevada, Sravan, Johnson, Leigh A., Edwards, Melissa, Graff-Radford, Neill R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Special Section: Blood-Based Biomarkers for Alzheimer's Disease & Related Dementias. (Editor: Henrik Zetterberg)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424013/
https://www.ncbi.nlm.nih.gov/pubmed/30923734
http://dx.doi.org/10.1016/j.dadm.2019.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424013/
https://www.ncbi.nlm.nih.gov/pubmed/30923734
http://dx.doi.org/10.1016/j.dadm.2019.01.006

Ejemplares similares